The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However…
Driven by product awareness, rising kidney stone prevalence, and an aging population, the Asia Pacific urological device market will grow at a modest rate through 2032, despite the short-term…
Although the global COVID-19 pandemic negatively impacted the Asia Pacific EP mapping and ablation device market in 2020, the market has shown strong recovery and will resume prepandemic growth…
Following recovery from the impact of the COVID-19 pandemic, the European neurostimulation device market will see modest growth through 2032, driven by ongoing product innovation and a focus on…
The US vascular access device market will grow slowly over the forecast period. On one hand, unit sales will be supported by steady growth in the underlying patient population undergoing medical…
The US pain management device market is characterized by ongoing product innovation to improve treatment efficacy and to address new indications, with new clinical evidence and pain management…
The US reconstructive small-joint implant market has largely recovered from the negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the near term; going forward,…
The US PV device market will be driven by the continued rise in adoption of various endovascular treatment techniques and innovative product launches supported by favorable reimbursement programs,…
The US IC device market is facing intense pricing pressure on established products, such as DES, limiting the overall market growth. However, steady uptake of novel, premium technologies has…
A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…
The Japanese TEO device market will see modest growth over the forecast period driven by growing adoption of minimally invasive treatment options like embolization, increasing product launches, and…
Over the forecast period, Latin American spinal implant market expansion will be driven by procedure volume growth due to an aging population and uptake of premium innovations such as 3-D–…
The US cardiac assist device market will continue to experience growth after recovering from the impact of the COVID-19 pandemic. The market will be driven by expanded use of cardiac assist devices…
The US neurostimulation device market is characterized by ongoing product innovation; iterative device improvements are regularly launching in established segments—such as the SCS and DBS device…